World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
147
Citations
85771
World Ranking
1273
National Ranking
739

Overview

Patrick Y. Wen is affiliated with Harvard University in the United States and has a research focus primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields, including Genetics, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, and Cancer Research.

The scientist has contributed extensively to research on glioma, with a substantial emphasis on glioma diagnosis and treatment. Their major research topics include:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Neuroblastoma Research and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Hypoxia, and Metabolism

Frequent co-authors collaborating with Patrick Y. Wen include:

  • David A. Reardon
  • Timothy F. Cloughesy
  • Eudocia Q. Lee
  • Keith L. Ligon
  • Michael Weller

The scientist's research has appeared in several notable publication venues, reflecting the areas of their scholarly activity:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Neuro-Oncology Advances
  • Clinical Cancer Research
  • Cancer Research

Key recent papers by Patrick Y. Wen include:

  • "Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions," published in 2020 in Neuro-Oncology
  • "Mechanisms and therapeutic implications of hypermutation in gliomas," published in 2020 in Nature
  • "Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma," published in 2023 in New England Journal of Medicine
  • "Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology," published in 2020 in Journal of the National Comprehensive Cancer Network
  • "Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial," published in 2020 in The Lancet Oncology

Best Publications

  • Malignant Gliomas in Adults

    Patrick Y Wen;Santosh Kesari

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

    Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen

  • AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang

  • Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma

    Erwin Van Meir;Constantinos G Hadjipanayis;Andrew D. Norden;Hui-Kuo Shu

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh

  • Epidemiology of Brain Metastases

    Lakshmi Nayak;Eudocia Quant Lee;Patrick Y. Wen

  • Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

    Timothy F. Cloughesy;Aaron Y. Mochizuki;Joey R. Orpilla;Willy Hugo

  • Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology

    M. J. Glantz;B. F. Cole;B. F. Cole;P. A. Forsyth;L. D. Recht;L. D. Recht

  • Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

    A. D. Norden;G. S. Young;K. Setayesh;A. Muzikansky

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

    Vivek Subbiah;Robert J. Kreitman;Zev A. Wainberg;Jae Yong Cho

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Patrick Y. Wen;Michael Weller;Eudocia Quant Lee;Brian M. Alexander

  • Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

    Paul G. Richardson;Hannah Briemberg;Sundar Jagannath;Patrick Y. Wen

  • Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases

    Eben Alexander;Thomas M. Moriarty;Roger B. Davis;Patrick Y. Wen

  • Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

    Hideho Okada;Michael Weller;Raymond Huang;Gaetano Finocchiaro

  • Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

    Amita Patnaik;Lee S. Rosen;Sara M. Tolaney;Anthony W. Tolcher

  • Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

    Leland Rogers;Igor Barani;Marc Chamberlain;Thomas J. Kaley

  • Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

    Daniel N Cagney;Allison M Martin;Paul J Catalano;Amanda J Redig

  • Management of brain metastases.

    P Y Wen;J S Loeffler

Frequent Co-Authors

David A. Reardon
David A. Reardon Harvard University
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Keith L. Ligon
Keith L. Ligon Harvard University
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
Brian M. Alexander
Brian M. Alexander Foundation Medicine
David Schiff
David Schiff University of Virginia
Michael D. Prados
Michael D. Prados University of California, San Francisco
Susan M. Chang
Susan M. Chang University of California, San Francisco
Rameen Beroukhim
Rameen Beroukhim Harvard University
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine or healthcare doesn't always mean you need to go to medical school. Several related online degrees offer excellent pathways into the industry, whether you want to start working quickly or move into leadership roles. If you are interested in patient care and want to join the workforce fast, consider fast track lpn programs that can have you working as a Licensed Practical Nurse in a shorter time frame.

For those seeking advanced practice and specialized care, especially in mental health, the fastest psych np program options provide an accelerated route to becoming a Psychiatric Mental Health Nurse Practitioner. Those drawn to the administrative side of healthcare will find that healthcare administration degrees can open doors to mid- and upper-level management positions.

Even further, aspiring leaders can explore the cheapest mha programs online, which combine affordability with specialized knowledge in health systems management. Each path offers unique opportunities for growth, flexibility, and meaningful impact in the healthcare field.

Best Scientists Citing Patrick Y. Wen

Trending Scientists

Recently Published Articles